<p>(A) Cellular proteins were detected in total cell lysates by immunoblotting analysis with anti-Dok1 and anti-BRK antibodies. β-tubulin expression served as a loading control. (B & C) SKBR3 and BT20 cells were fractionated into the cytosolic, membrane, nuclear and cytoskeleton fractions and subjected to immunoblotting analysis for the detection of BRK and Dok1. β-tubulin and Sam68 were used as controls for the cytosolic/membrane and nuclear compartments, respectively. (D) Stable BRK knockdown was performed on parental breast cancer cell lines SKBR3 using shRNA lentiviral vector plasmids against BRK and analyzed as indicated.</p
BACKGROUND: Breast tumour kinase (BRK) is a newly identified non-receptor protein tyrosine kinase fr...
<p>Immunoblots showing the expression levels of Cdc7 and Dbf4 in tumor cell lines. β-actin levels in...
Breast cancer is the second most lethal form of diagnosed cancer in women today. Women who have inhe...
<p>(A) HEK 293 cells or HEK 293-BRK-YF stable cell line were treated with a protein synthesis inhibi...
Breast cancer is unanimously considered a highly heterogeneous disease due to its diverse molecular ...
<p>(A) HEK 293 cells were transfected with empty vector, Myc-BRK-WT, Myc-BRK-YF, GFP-Dok1 or co-tran...
<p>(A) Schematic diagram of Dok1 showing different deletion and point mutants. (B) The Dok1 deletion...
Brk, a tyrosine kinase expressed in a majority of breast tumors, but not normal mammary tissue, prom...
© 2009 American Society for Investigative Pathology. The full and final published article is availab...
<p>(A) HEK 293 stable sub-cell lines were transduced with mCherry-Dok1 using adenoviral vector. Cell...
Breast tumor kinase (BRK), also known as protein tyrosine kinase 6 (PTK6), is a non-receptor tyrosin...
Breast tumor kinase (BRK), also known as protein tyrosine kinase 6 (PTK6), is a non-receptor tyrosin...
INTERACTION BETWEEN BRK AND HER2 IN BREAST CANCER Midan Ai, Ph.D. Supervisory Professor: Zhen Fan, M...
<p>A Forty-eight hours after transfection, the expression of BRG1 in MDA-MB-231 and BT-549 cells was...
Tyrosine kinases orchestrate key cellular signaling pathways and their dysregulation is often associ...
BACKGROUND: Breast tumour kinase (BRK) is a newly identified non-receptor protein tyrosine kinase fr...
<p>Immunoblots showing the expression levels of Cdc7 and Dbf4 in tumor cell lines. β-actin levels in...
Breast cancer is the second most lethal form of diagnosed cancer in women today. Women who have inhe...
<p>(A) HEK 293 cells or HEK 293-BRK-YF stable cell line were treated with a protein synthesis inhibi...
Breast cancer is unanimously considered a highly heterogeneous disease due to its diverse molecular ...
<p>(A) HEK 293 cells were transfected with empty vector, Myc-BRK-WT, Myc-BRK-YF, GFP-Dok1 or co-tran...
<p>(A) Schematic diagram of Dok1 showing different deletion and point mutants. (B) The Dok1 deletion...
Brk, a tyrosine kinase expressed in a majority of breast tumors, but not normal mammary tissue, prom...
© 2009 American Society for Investigative Pathology. The full and final published article is availab...
<p>(A) HEK 293 stable sub-cell lines were transduced with mCherry-Dok1 using adenoviral vector. Cell...
Breast tumor kinase (BRK), also known as protein tyrosine kinase 6 (PTK6), is a non-receptor tyrosin...
Breast tumor kinase (BRK), also known as protein tyrosine kinase 6 (PTK6), is a non-receptor tyrosin...
INTERACTION BETWEEN BRK AND HER2 IN BREAST CANCER Midan Ai, Ph.D. Supervisory Professor: Zhen Fan, M...
<p>A Forty-eight hours after transfection, the expression of BRG1 in MDA-MB-231 and BT-549 cells was...
Tyrosine kinases orchestrate key cellular signaling pathways and their dysregulation is often associ...
BACKGROUND: Breast tumour kinase (BRK) is a newly identified non-receptor protein tyrosine kinase fr...
<p>Immunoblots showing the expression levels of Cdc7 and Dbf4 in tumor cell lines. β-actin levels in...
Breast cancer is the second most lethal form of diagnosed cancer in women today. Women who have inhe...